EX-99.1 2 dex991.htm MONTHLY OPERATING REPORT OF ACCENTIA BIOPHARMACEUTICALS, INC. Monthly Operating Report of Accentia Biopharmaceuticals, Inc.

Exhibit 99.1

UNITED STATES BANKRUPTCY COURT

MIDDLE DISTRICT OF FLORIDA

TAMPA DIVISION

 

In re:  

ACCENTIA BIOPHARMACEUTICALS, INC.

  Case No. 8:08-bk-17795-KRM

Debtor.

 

                                                             /

 

DEBTOR’S MONTHLY FINANCIAL REPORT FOR THE

PERIOD OF NOVEMBER 10, 2008 THROUGH NOVEMBER 30, 2008

Comes now the above-named Debtor and files its Periodic Financial Reports in accordance with the Guidelines established by the United States Trustee and FRBP 2015.

 

/s/ Charles A. Postler

Charles A. Postler
Florida Bar No. 455318
Stichter Riedel Blain & Prosser, P.A.
110 East Madison Street, Suite 200
Tampa, Florida 33602
(813) 229-0144 – Phone
(813) 229-1811 – Fax
cpostler.ecf@srbp.com
Attorneys for Debtor

 

MOR-1


SCHEDULE OF RECEIPTS AND DISBURSEMENTS

FOR THE PERIOD BEGINNING: November 10, 2008 AND ENDING November 30, 2008

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  Case Number: 8:08-bk-17795-KRM

Date of Petition: November 10, 2008

 

 

     CURRENT MONTH    CUMULATIVE
PETITION TO DATE

1. FUNDS AT BEGINNING OF PERIOD

   $ 281,590.31    $ 281,590.31

2. RECEIPTS:

     

A. Cash Sales

     

B. Accounts Receivable

     

C. Other Receipts (See MOR-3)

     63,134.26      63,134.26

D. Transfer from subsidiaries - TEAMM

     215,644.58      215,644.58

- Accentia Specialty Pharmacy

     6,352.94      6,352.94

- Analytica

     30,731.41      30,731.41

3. TOTAL RECEIPTS (Lines 2A+2B+2C)

     315,863.19      315,863.19

4. TOTAL FUNDS AVAILABLE FOR OPERATIONS (1+3)

     597,453.50      597,453.50

5. DISBURSEMENTS

     

A. Advertising

     

B. Bank Charges

     

C. Contract Labor

     

D. Fixed Asset Payments (not incl in N)

     

E. Insurance

     94,470.08      94,470.08

F. Inventory Payments (See Attach. 2)

     

G. Leases

     

H. Manufacturing Supplies

     

I. Office Supplies

     

J. Payroll – Net (see Attachment 4B)

     113,659.09      113,659.09

K. Professional Fees (Accounting/Legal)

     

L. Rent

     738.30      738.30

M. Repairs and Maintenance

     

N. Secured Creditor Payments (Attach. 2)

     

O. Taxes Paid – Payroll (Attach. 4C)

     46,686.10      46,686.10

P. Taxes Paid – Sales and Use (Attach. 4C)

     

Q. Taxes Paid – Other (Attach. 4C)

     

R. Telephone

     3,242.57      3,242.57

S. Travel and Entertainment

     1,990.57      1,990.57

Y. U.S. Trustee Quarterly Fees

     

U. Utilities

     

V. Vehicle Expenses

     

W. Other Operating Expenses (See MOR-3)

     2,000.00      2,000.00

X. Transfer to subsidiaries – Analytica

     42,136.99      42,136.99

TOTAL DISBURSEMENTS (Sum of 5A thru W)

     304,923.69      304,923.69

ENDING BALANCE (Line 4 Minus Line 6)(c)

   $ 292,529.80    $ 292,529.80

I declare under penalty of perjury that this statement and the accompanying documents and reports are true and correct to the best of my knowledge and belief.

 

This 24th day of December, 2008     

/s/ Alan M. Pearce

     (Signature)

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This figure will not change from month to month. It is always the amount of funds on hand as of the date of the petition.
(c) These two amounts will always be the same if form is completed correctly.

 

MOR-2


MONTHLY SCHEDULE OF RECEIPTS AND DISBURSEMENTS (cont’d)

Detail of Other Receipts and Other Disbursements

OTHER RECEIPTS:

Describe Each Item of Other Receipt and List Amount of Receipt. Write totals on Page MOR-2, Line 2C.

 

Description

   Current Month    Cumulative
Petition to Date

Collections for TEAMM receivables

   $ 56,577.13    $ 56,577.13

Collections for A.S.P. receivables

     6,212.70      6,212.70

COBRA checks

     344.43      344.43

TOTAL OTHER RECEIPTS

   $ 63,134.26    $ 63,134.26
             

“Other Receipts” includes Loans from Insiders and other sources (i.e. Officer/Owner, related parties directors, related corporations, etc.). Please describe below: N/A

 

Loan Amount

  

Source of Funds

  

Purpose

  

Repayment Schedule

N/A

        

OTHER DISBURSEMENTS:

Describe Each Item of Other Disbursement and List Amount of Disbursement. Write totals on Page MOR-2, Line 5W.

 

Description

   Current Month    Cumulative
Petition to Date

R.R. Donnelly printing expenses

   $ 2,000.00    $ 2,000.00

TOTAL OTHER DISBURSEMENTS

   $ 2,000.00    $ 2,000.00

NOTE: Attach a current Balance Sheet and Income (Profit & Loss) Statement.

 

MOR-3


ATTACHMENT 1

MONTHLY ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.   Case Number: 8:08-bk-17795-KRM

Reporting Period beginning November 10, 2008

  Period ending November 30, 2008

ACCOUNTS RECEIVABLE AT PETITION DATE: N/A

ACCOUNTS RECEIVABLE RECONCILIATION

(Include all accounts receivable, pre-petition and post-petition, including charge card sales which have not been received):

 

Beginning of Month Balance (a)

   $             

PLUS: Current Month New Billings

  

MINUS: Collection During the Month(b)

   $  

PLUS/MINUS: Adjustments or Write-offs*

   $  

End of Month Balance(c)

   $  

 

*       For any adjustments or Write-offs provide explanation and supporting documentation, if applicable:

 

 

 

POST PETITION ACCOUNTS RECEIVABLE AGING

(Show the total for each aging category for all accounts receivable)

 

0-30 Days

  31-60 Days   61-90 Days   Over 90 Days   Total(c)
$               $                $                $                $             

For any receivables in the “Over 90 Days” category, please provide the following: N/A

 

Receivable Customer

   Date   

Status (Collection efforts taken, estimate

of collectability, write-off, disputed

account, etc.)

N/A

     

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This must equal the number reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 2B).
(c) These two amounts must equal.

 

MOR-4


ATTACHMENT 2

MONTHLY ACCOUNTS PAYABLE AND SECURED PAYMENTS REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  Case Number: 8:08-bk-17795-KRM

Reporting Period beginning November 10, 2008

  Period ending November 30, 2008

In the space below list all invoices or bills incurred and not paid since the filing of the petition. Do not include amounts owed prior to filing the petition. In the alternative, a computer generated list of payables may be attached provided all information requested below is included. SEE ATTACHED

POST-PETITION ACCOUNTS PAYABLE

 

Date Incurred

   Date Outstanding   

Vendor

  

Description

   Amount
           
           
        

TOTAL AMOUNT(b)

  

 

¨ Check here if pre-petition debts have been paid. Attach an explanation and copies of supporting documentation.

 

ACCOUNTS PAYABLE RECONCILIATION (Post Petition Unsecured Debt Only)

 

Opening Balance(a)

   $ 0

PLUS: New Indebtedness Incurred This Month

     94,922.84

MINUS: Amount Paid on Post Petition, Accounts Payable This Month

     76,085.28

PLUS/MINUS: Adjustments*

     *

Ending Month Balance(c)

   $ 18,837.56

 

*       For any adjustments provide explanation and supporting documentation, if applicable.

 

 

SECURED PAYMENTS REPORT

List the status of Payments to Secured Creditors and Lessors (Post Petition Only). If you have entered into a modification agreement with a secured creditor/lessor, consult with your attorney and the United States Trustee Program prior to completing this section).

 

Secured Creditor/Lessor

   Date
Payment
Due This
Month
   Amount Paid
This Month
   Number of
Post Petition
Payments
Delinquent
   Total Amount of
Post Petition
Payments
Delinquent

N/A

           

Total(d)

           

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be zero.
(b, c) The total of line (b) must equal line (c).
(d) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5N).

 

MOR-5


ATTACHMENT 3

INVENTORY AND FIXED ASSETS REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008   Period ending November 30, 2008

INVENTORY REPORT

 

INVENTORY BALANCE AT PETITION DATE:

   $                 N/A

INVENTORY RECONCILIATION:

     

Inventory Balance at Beginning of Month(a)

   $     

PLUS: Inventory Purchased During Month

   $     

MINUS: Inventory Used or Sold

   $     

PLUS/MINUS: Adjustments or Write-downs*

   $     

Inventory on Hand at End of Month

   $     

METHOD OF COSTING INVENTORY:                                         

 

*       For any adjustments or write-downs provide explanation and supporting documentation, if applicable.

 

INVENTORY AGING

 

Less than 6

months old

    6 months to 2
years old
    Greater than 2
years old
    Considered
Obsolete
         Total  
  %     %     %     %   =    100 %*

 

* Aging Percentages must equal 100%.

¨ Check here if inventory contains perishable items.

 

Description of Obsolete Inventory:  

 

 

FIXED ASSET REPORT

FIXED ASSETS FAIR MARKET VALUE AT PETITION DATE(b): $95,604.47

(Includes Property, Plant and Equipment)

 

BRIEF DESCRIPTION (First Report Only):

 

 

 

 

 

FIXED ASSETS RECONCILIATION:

 

Fixed Asset Book Value at Beginning of Month(a) (b)

   $ 95,604.47

MINUS: Depreciation Expense

   $ 8,886.27

PLUS: New Purchases

  

PLUS/MINUS: Adjustments or Write-downs*

  

Ending Monthly Balance

   $ 86,718.20

 

* For any adjustments or write-downs, provide explanation and supporting documentation, if applicable.

BRIEF DESCRIPTION OF FIXED ASSETS PURCHASED OR DISPOSED OF DURING THE REPORTING PERIOD: N/A

n/a

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) Fair Market Value is the amount at which fixed assets could be sold under current economic conditions.

Book Value is the cost of the fixed assets minus accumulated depreciation and other adjustments.

 

MOR-6


ATTACHMENT 4A

MONTHLY SUMMARY OF BANK ACTIVITY - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.   Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008   Period ending November 30, 2008

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK: Wachovia Bank, NA   BRANCH:                                         

ACCOUNT NAME: Accentia Master Account DIP

  ACCOUNT NUMBER:*********1478
PURPOSE OF ACCOUNT: MASTER ACCOUNT  

 

Ending Balance per Bank Statement

   $ 440,963.02

Plus Total Amount of Outstanding Deposits

   $ 0

Minus Total Amount of Outstanding Checks and other debits*

   $ 0

Minus Service Charges

   $ 0

Ending Balance per Check Register**(a)

   $ 440,963.02

 

* Debit cards are used by N/A
** If Closing Balance is negative, provide explanation: N/A

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

11/24/08

   $ 1,043.63    Accentia operating acct    ZBA    ZBA transfer

11/24/08

   $ 2,000.00    RR Donnelly    Printing    Required a wire

11/25/08

   $ 36,275.68    Analytica    ZBA    ZBA transfer

11/26/08

   $ 25,930.15    Accentia operating acct    ZBA    ZBA transfer

11/28/08

   $ 5,861.31    Analytica    ZBA    ZBA transfer

11/28/08

   $ 33,700.67    Accentia operating acct    ZBA    ZBA transfer

TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS

“Total Amount of Outstanding Checks and other debits”, listed above, includes:

 

$            Transferred to Payroll Account
$            Transferred to Tax Account

 

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-7


ATTACHMENT 5A

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.   Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008   Period ending November 30, 2008
NAME OF BANK: Wachovia Bank, NA   BRANCH: Tampa
ACCOUNT NAME: Accentia Operating   ACCOUNT NUMBER: *********1478
PURPOSE OF ACCOUNT: MASTER ACCOUNT  

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included. NONE

 

DATE

  

CHECK NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
         TOTAL    $             

 

MOR-8


ATTACHMENT 4A2

MONTHLY SUMMARY OF BANK ACTIVITY - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

   Case Number: 8:08-bk-17795-KRM

Reporting Period beginning November 10, 2008

  

Period ending November 30, 2008

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK: Wachovia Bank, NA

  

BRANCH:                                         

ACCOUNT NAME: Accentia Operating Account DIP

  

ACCOUNT NUMBER: *********1494

PURPOSE OF ACCOUNT: OPERATING

  

 

Ending Balance per Bank Statement

   $ 0

Plus Total Amount of Outstanding Deposits

   $ 0

Minus Total Amount of Outstanding Checks and other debits*

   $ 148,433.22

Minus Service Charges

   $ 0

Ending Balance per Check Register**(a)

   $ 148,433.22

 

* Debit cards are used by N/A
** If Closing Balance is negative, provide explanation: N/A

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (¨ Check here if cash disbursements were authorized by United States Trustee) N/A

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

11/24

   $ 448.29    Beneflex    Payroll    Direct debit

11/24

   $ 595.34    Beneflex    Payroll    Direct debit

11/25

   $ 11,455.22    Accentia Master acct    ZBA    ZBA transfer

11/25

   $ 20,126.80    A.D.P.    Payroll    Wire for payroll

11/25

   $ 26,559.30    A.D.P.    Payroll   

Wire for payroll

11/28

   $ 131.87    Beneflex    Payroll   

Direct debit

TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS

“Total Amount of Outstanding Checks and other debits”, listed above, includes:

$            Transferred to Payroll Account

$            Transferred to Tax Account

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-9


ATTACHMENT 5A2

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008    Period ending November 30, 2008

 

NAME OF BANK: Wachovia Bank, NA

  

BRANCH: Tampa

ACCOUNT NAME: Accentia Operating

  

ACCOUNT NUMBER: *********1494

PURPOSE OF ACCOUNT: OPERATING

  

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included.

SEE SEPARATE REGISTER

 

DATE

  

CHECK NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
         TOTAL    $  

 

MOR-10


ATTACHMENT 4B

MONTHLY SUMMARY OF BANK ACTIVITY - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008    Period ending November 30, 2008

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm.

 

NAME OF BANK: N/A    BRANCH: N/A
ACCOUNT NAME:                                             ACCOUNT NUMBER:                                         
PURPOSE OF ACCOUNT: PAYROLL   

 

Ending Balance per Bank Statement

   $             

Plus Total Amount of Outstanding Deposits

   $  

Minus Total Amount of Outstanding Checks and other debits*

   $  

Minus Service Charges

   $  

Ending Balance per Check Register**(a)

   $  

 

* Debit cards must not be issued on this account.

 

** If Closing Balance is negative, provide explanation:

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

  

Amount

  

Payee

  

Purpose

   Reason for Cash Disbursement
           
           

The following non-payroll disbursements were made from this account:

 

Date

  

Amount

  

Payee

  

Purpose

   Reason for Disbursement from account
           
           

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-11


ATTACHMENT 5B

CHECK REGISTER - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008    Period ending November 30, 2008

 

NAME OF BANK: N/A    BRANCH: N/A
ACCOUNT NAME:                                             ACCOUNT NUMBER:                                         
PURPOSE OF ACCOUNT: PAYROLL   

Account for all disbursements, including voids, lost payments, stop payment, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included.

 

DATE

  

CHECK NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
         TOTAL    $  

 

MOR-12


ATTACHMENT 4C

MONTHLY SUMMARY OF BANK ACTIVITY - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008    Period ending November 30, 2008

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found on the United States Trustee website, http://www.usdoj.gov/ust/r21/index.htm.

 

NAME OF BANK: N/A

  

BRANCH: N/A

ACCOUNT NAME:                                              

  

ACCOUNT NUMBER:                                         

PURPOSE OF ACCOUNT: TAX

  

 

Ending Balance per Bank Statement

   $             

Plus Total Amount of Outstanding Deposits

   $  

Minus Total Amount of Outstanding Checks and other debits*

   $  

Minus Service Charges

   $  

Ending Balance per Check Register**(a)

   $  

 

* Debit cards must not be issued on this account.
** If Closing Balance is negative, provide explanation: N/A

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

11/25/08

   $ 20,126.80    A.D.P.    Payroll taxes for Accentia    Wired to ADP from Accentia Operating account

11/25/08

   $ 26,559.30    A.D.P.    Payroll taxes for TEAMM    Wired to A.D.P. from Accentia Operating account

The following non-tax disbursements were made from this account:

 

Date

  

Amount

  

Payee

  

Purpose

   Reason for Disbursement from account

N/A

           

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-13


ATTACHMENT 5C

CHECK REGISTER - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

   Case Number: 8:08-bk-17795-KRM

Reporting Period beginning November 10, 2008

  

Period ending November 30, 2008

 

NAME OF BANK: N/A

  

BRANCH: N/A

ACCOUNT NAME:                                              

  

ACCOUNT NUMBER:                                         

PURPOSE OF ACCOUNT: TAX

  

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer-generated check register can be attached to this report, provided all the information requested below is included.

 

DATE

  

CHECK NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
         TOTAL(d)    $  

SUMMARY OF TAXES PAID

 

Payroll Taxes Paid(a)

   $  

Sales & Use Taxes Paid(b)

   $             

Other Taxes Paid(c)

   $  

TOTAL(d)

   $  

 

(a) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5O).
(b) This number is reported in the “Current Month” column of Schedule or Receipts and Disbursements (Page MOR-2, Line 5P).
(c) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5Q).
(d) These two lines must be equal.

 

MOR-14


ATTACHMENT 4D

INVESTMENT ACCOUNTS AND PETTY CASH REPORT

INVESTMENT ACCOUNTS

Each savings and investment account, i.e. certificates of deposits, money market accounts, stocks and bonds, etc., should be listed separately. Attach copies of account statements.

Type of Negotiable

 

Instrument

   Face
Value
   Purchase
Price
   Date of
Purchase
  Current
Market Value

N/A

          
         TOTAL(a)   $  

PETTY CASH REPORT

The following Petty Cash Drawers/Accounts are maintained:

 

Location of Box/Account

   (Column 2)
Maximum Amount of
Cash in
Drawer/Acct.
   (Column 3)
Amount of
Petty Cash On
Hand At End of
Month
  (Column 4)
Difference
between
(Column 2)
and (Column 3)

N/A

       
      TOTAL(b)   $  

For any Petty Cash Disbursements over $100 per transaction, attach copies of receipts. If there are no receipts, provide an explanation                                                                                       

TOTAL INVESTMENT ACCOUNTS AND PETTY CASH (a+ b)         $             (c)

 

(c) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-15


ATTACHMENT 6

MONTHLY TAX REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning November 10, 2008    Period ending November 30, 2008

TAXES OWED AND DUE

Report all unpaid post-petition taxes including Federal and State withholding FICA, State sales tax, property tax, unemployment tax, State workmen’s compensation, etc.

 

Name of Taxing Authority

   Date Payment
Due
   Description    Amount    Date of Last
Tax Return
Filed
   Tax Return
Period

N/A

              
      TOTAL    $                   

 

MOR-16


ATTACHMENT 7

SUMMARY OF OFFICER OR OWNER COMPENSATION

SUMMARY OF PERSONNEL AND INSURANCE COVERAGES

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  

Case Number: 8:08-bk-17795-KRM

Reporting Period beginning November 10, 2008

  

Period ending November 30, 2008

Report all forms of compensation received by or paid on behalf of the Officer or Owner during the month. Include car allowances, payments to retirement plans, loan repayments, payments of Officer/Owner’s personal expenses, insurance premium payments, etc. Do not include reimbursement for business expenses Officer or Owner incurred and for which detailed receipts are maintained in the accounting records.

 

Name of Officer or Owner

  

Title

  

Payment Description

   Amount Paid

Samuel Duffey

   President, General Counsel    Salary    $ 6,980.77

Alan Pearce

   C.F.O.    Salary      5,618.56

James McNulty

   Treasurer    Salary      3,923.14

PERSONNEL REPORT

 

      Full Time    Part Time

Number of employees at beginning of period

   20    1

Number hired during the period

   0    0

Number terminated or resigned during period

   5    0

Number of employees on payroll at end of period

   15    1

CONFIRMATION OF INSURANCE

List all policies of insurance in effect, including but not limited to workers’ compensation, liability, fire, theft, comprehensive, vehicle, health and life. For the first report, attach a copy of the declaration sheet for each type of insurance. For subsequent reports, attach a certificate of insurance for any policy in which a change occurs during the month (new carrier, increased policy limits, renewal, etc.). SEE ATTACHED

 

Agent and/or Carrier

   Phone Number    Policy Number    Coverage
Type
   Expiration
Date
   Date
Premium Due
              
              

The following lapse in insurance coverage occurred this month: N/A

 

Policy Type

   Date Lapsed    Date Reinstated    Reason for Lapse
        
        

 

  ¨ Check here if U. S. Trustee has been listed as Certificate Holder for all insurance policies.

 

MOR-17


ATTACHMENT 8

SIGNIFICANT DEVELOPMENTS DURING REPORTING PERIOD

Information to be provided on this page, includes, but is not limited to: (1) financial transactions that are not reported on this report, such as the sale of real estate (attach closing statement); (2) non-financial transactions, such as the substitution of assets or collateral; (3) modifications to loan agreements; (4) change in senior management, etc. Attach any relevant documents. N/A

 

 

 

 

 

 

 

 

 

 

We anticipate filing a Plan of Reorganization and Disclosure Statement on or before                     .

 

MOR-18